Logo image of GRDN

GUARDIAN PHRMCY SERVICES-A (GRDN) Stock Fundamental Analysis

USA - NYSE:GRDN - US40145W1018 - Common Stock

25.68 USD
+0.73 (+2.93%)
Last: 10/20/2025, 2:04:12 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to GRDN. GRDN was compared to 39 industry peers in the Consumer Staples Distribution & Retail industry. While GRDN seems to be doing ok healthwise, there are quite some concerns on its profitability. While showing a medium growth rate, GRDN is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

GRDN had negative earnings in the past year.
In the past year GRDN had a positive cash flow from operations.
GRDN had positive earnings in 4 of the past 5 years.
GRDN had a positive operating cash flow in each of the past 5 years.
GRDN Yearly Net Income VS EBIT VS OCF VS FCFGRDN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M -100M

1.2 Ratios

GRDN has a Return On Assets of -25.70%. This is amonst the worse of the industry: GRDN underperforms 87.18% of its industry peers.
With a Return On Equity value of -54.00%, GRDN is not doing good in the industry: 79.49% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -25.7%
ROE -54%
ROIC N/A
ROA(3y)-3.89%
ROA(5y)0.88%
ROE(3y)30.17%
ROE(5y)42.1%
ROIC(3y)N/A
ROIC(5y)N/A
GRDN Yearly ROA, ROE, ROICGRDN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 50 -50

1.3 Margins

GRDN has a worse Gross Margin (19.63%) than 61.54% of its industry peers.
In the last couple of years the Gross Margin of GRDN has remained more or less at the same level.
GRDN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 19.63%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.77%
GM growth 5Y-0.64%
GRDN Yearly Profit, Operating, Gross MarginsGRDN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 5 -5 10 15 20

More info and screens

6

2. Health

2.1 Basic Checks

GRDN does not have a ROIC to compare to the WACC, probably because it is not profitable.
GRDN has more shares outstanding than it did 1 year ago.
The number of shares outstanding for GRDN has been increased compared to 5 years ago.
The debt/assets ratio for GRDN has been reduced compared to a year ago.
GRDN Yearly Shares OutstandingGRDN Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 20M 40M 60M
GRDN Yearly Total Debt VS Total AssetsGRDN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

An Altman-Z score of 8.45 indicates that GRDN is not in any danger for bankruptcy at the moment.
The Altman-Z score of GRDN (8.45) is better than 94.87% of its industry peers.
There is no outstanding debt for GRDN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 8.45
ROIC/WACCN/A
WACC8.69%
GRDN Yearly LT Debt VS Equity VS FCFGRDN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 50M 100M

2.3 Liquidity

A Current Ratio of 1.18 indicates that GRDN should not have too much problems paying its short term obligations.
GRDN has a Current ratio (1.18) which is in line with its industry peers.
A Quick Ratio of 0.88 indicates that GRDN may have some problems paying its short term obligations.
GRDN has a Quick ratio of 0.88. This is in the better half of the industry: GRDN outperforms 71.79% of its industry peers.
Industry RankSector Rank
Current Ratio 1.18
Quick Ratio 0.88
GRDN Yearly Current Assets VS Current LiabilitesGRDN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

5

3. Growth

3.1 Past

The earnings per share for GRDN have decreased strongly by -567.05% in the last year.
GRDN shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 17.42%.
Measured over the past years, GRDN shows a quite strong growth in Revenue. The Revenue has been growing by 11.96% on average per year.
EPS 1Y (TTM)-567.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%576.33%
Revenue 1Y (TTM)17.42%
Revenue growth 3Y15.75%
Revenue growth 5Y11.96%
Sales Q2Q%5.46%

3.2 Future

GRDN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 42.67% yearly.
The Revenue is expected to grow by 8.62% on average over the next years. This is quite good.
EPS Next Y159.58%
EPS Next 2Y67.33%
EPS Next 3Y42.67%
EPS Next 5YN/A
Revenue Next Year14.43%
Revenue Next 2Y8.2%
Revenue Next 3Y8.62%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
GRDN Yearly Revenue VS EstimatesGRDN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
GRDN Yearly EPS VS EstimatesGRDN Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 0 0.5 -0.5 1 -1

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for GRDN. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 26.23 indicates a quite expensive valuation of GRDN.
GRDN's Price/Forward Earnings is on the same level as the industry average.
The average S&P500 Price/Forward Earnings ratio is at 22.94. GRDN is around the same levels.
Industry RankSector Rank
PE N/A
Fwd PE 26.23
GRDN Price Earnings VS Forward Price EarningsGRDN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, GRDN is valued a bit more expensive than the industry average as 64.10% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 46.41
EV/EBITDA N/A
GRDN Per share dataGRDN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

GRDN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
GRDN's earnings are expected to grow with 42.67% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y67.33%
EPS Next 3Y42.67%

More info and screens

0

5. Dividend

5.1 Amount

GRDN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GUARDIAN PHRMCY SERVICES-A

NYSE:GRDN (10/20/2025, 2:04:12 PM)

25.68

+0.73 (+2.93%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)08-11 2025-08-11/amc
Earnings (Next)11-10 2025-11-10
Inst Owners83.31%
Inst Owner Change0%
Ins Owners3.92%
Ins Owner Change33.23%
Market Cap1.63B
Analysts84.44
Price Target28.56 (11.21%)
Short Float %2.85%
Short Ratio1.79
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-14.87%
Min EPS beat(2)-18.3%
Max EPS beat(2)-11.45%
EPS beat(4)1
Avg EPS beat(4)-287.21%
Min EPS beat(4)-1131.99%
Max EPS beat(4)12.89%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)1.43%
Min Revenue beat(2)0.51%
Max Revenue beat(2)2.36%
Revenue beat(4)3
Avg Revenue beat(4)1.07%
Min Revenue beat(4)-0.25%
Max Revenue beat(4)2.36%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.44%
PT rev (3m)0%
EPS NQ rev (1m)-5.56%
EPS NQ rev (3m)-2.86%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.69%
Revenue NQ rev (1m)0.26%
Revenue NQ rev (3m)5.2%
Revenue NY rev (1m)0%
Revenue NY rev (3m)3.78%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 26.23
P/S 1.23
P/FCF 46.41
P/OCF 30.12
P/B 9.59
P/tB 21.45
EV/EBITDA N/A
EPS(TTM)-1.52
EYN/A
EPS(NY)0.98
Fwd EY3.81%
FCF(TTM)0.55
FCFY2.15%
OCF(TTM)0.85
OCFY3.32%
SpS20.95
BVpS2.68
TBVpS1.2
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -25.7%
ROE -54%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 19.63%
FCFM 2.64%
ROA(3y)-3.89%
ROA(5y)0.88%
ROE(3y)30.17%
ROE(5y)42.1%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.77%
GM growth 5Y-0.64%
F-Score5
Asset Turnover3.72
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 87.56%
Cap/Sales 1.43%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.18
Quick Ratio 0.88
Altman-Z 8.45
F-Score5
WACC8.69%
ROIC/WACCN/A
Cap/Depr(3y)87.95%
Cap/Depr(5y)73.67%
Cap/Sales(3y)1.52%
Cap/Sales(5y)1.37%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-567.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%576.33%
EPS Next Y159.58%
EPS Next 2Y67.33%
EPS Next 3Y42.67%
EPS Next 5YN/A
Revenue 1Y (TTM)17.42%
Revenue growth 3Y15.75%
Revenue growth 5Y11.96%
Sales Q2Q%5.46%
Revenue Next Year14.43%
Revenue Next 2Y8.2%
Revenue Next 3Y8.62%
Revenue Next 5YN/A
EBIT growth 1Y-253.67%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year259.18%
EBIT Next 3Y57.99%
EBIT Next 5YN/A
FCF growth 1Y-26.08%
FCF growth 3Y-5.46%
FCF growth 5Y-0.01%
OCF growth 1Y-18.16%
OCF growth 3Y-0.31%
OCF growth 5Y0.63%